Following young people with new joint inflammation and related autoimmune diseases
Observes children and young adults newly diagnosed with inflammatory arthritis or lupus over time.
Plain-language title generated from the registry record
Registry title: Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Key facts
- Where
- Brussels, BelgiumSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 50 years old?
Source: NCT07000916, who can take part
Where in Belgium
- UCLouvainBrussels, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Université Catholique de Louvain
- Trial code
- NCT07000916
- Record updated
- 3 June 2025
- Original description
Population:Read full original descriptionShow less
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults. Optimization of Clinical Response, Remission, Quality of Life and Analysis of Prognostic Markers
Population:
Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic sclerosis dSS).
Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.
These 5 cohorts will be subject to standardized clinical monitoring.
Inclusion: Diagnosis of juvenile idiopathic arthritis, rheumatoid arthritis and seronegative / psoriatic / undifferentiated arthritis, systemic lupus erythematosus or diffuse systemic sclerosis (ACR criteria); Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.
Exclusion: > 50 years old; Treated for > 3 months.